Myeloma Today: Winter 2026
The 2026 Winter Edition of Myeloma Today highlights IMF Chief Medical Officer Dr. Joseph Mikhael’s top 10 myeloma research abstracts from the American Society of Hematology (ASH) Annual Meeting & Exposition, including a discussion on in vivo CAR T-cell therapy and key results from the MajesTEC-3 trial. It also honors the legacy of IMF co-founder Dr. Brian G.M. Durie, shares insights from patient advocates at ASH, provides updates from the IMF Asian Myeloma Network (AMN) and IMF Latin American Myeloma Network (LAMN), and outlines IMF advocacy efforts to reduce barriers to care.